Literature DB >> 400510

Sick sinus syndrome.

J T Bigger, J A Reiffel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 400510     DOI: 10.1146/annurev.me.30.020179.000515

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  8 in total

1.  Rundown of the hyperpolarization-activated KAT1 channel involves slowing of the opening transitions regulated by phosphorylation.

Authors:  X D Tang; T Hoshi
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

Review 2.  The mammalian sinoatrial node.

Authors:  T Opthof
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

Review 3.  Pharmacological cardioversion of atrial fibrillation: current management and treatment options.

Authors:  Giuseppe Boriani; Igor Diemberger; Mauro Biffi; Cristian Martignani; Angelo Branzi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Sinus node dysfunction during long-term lithium treatment.

Authors:  M Rosenqvist; L Bergfeldt; H Aili; A A Mathé
Journal:  Br Heart J       Date:  1993-10

Review 5.  The cumulative risks of prolapsing mitral valve. 40 years of follow-up.

Authors:  D W Chapman
Journal:  Tex Heart Inst J       Date:  1994

6.  Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers.

Authors:  Mihoko Kawabata; Yasuhiro Yokoyama; Takeshi Sasaki; Susumu Tao; Kensuke Ihara; Yasuhiro Shirai; Tetsuo Sasano; Masahiko Goya; Tetsushi Furukawa; Mitsuaki Isobe; Kenzo Hirao
Journal:  Clin Pharmacol       Date:  2015-02-16

Review 7.  Pacemaker activity of the human sinoatrial node: an update on the effects of mutations in HCN4 on the hyperpolarization-activated current.

Authors:  Arie O Verkerk; Ronald Wilders
Journal:  Int J Mol Sci       Date:  2015-01-29       Impact factor: 5.923

Review 8.  Pharmacologic Approach to Sinoatrial Node Dysfunction.

Authors:  Pietro Mesirca; Vadim V Fedorov; Thomas J Hund; Angelo G Torrente; Isabelle Bidaud; Peter J Mohler; Matteo E Mangoni
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-10-05       Impact factor: 13.820

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.